Jamieson Wellness (JWEL) ran 10% after receiving an unsolicited offer that triggered a strategic review, which could attract more bids given the growth profile…

… and relatively inelastic demand within consumer discretionary, thanks to an aging population and a health-focused younger demographic.

With those two dynamics working for it, private capital should be more than willing to look past some near-term margin compression as new geographies mature…

… leaving another ~15% upside from here if a deal gets done at JWEL’s long-term average valuation, similar to recent Canadian take-privates we’ve seen.

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.

You might be interested in…